These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 15581064)
1. Chemotherapeutic response with single agent gemcitabine in metastatic Bellini duct tumor. Slovin SF; Berg W; Olgac S; Reuter V; Scher H Cancer Invest; 2004; 22(5):818-21. PubMed ID: 15581064 [No Abstract] [Full Text] [Related]
2. Remarkable shrinkage of sarcomatoid renal cell carcinoma with single-agent gemcitabine. Fujiwara Y; Kiura K; Tabata M; Takigawa N; Hotta K; Umemura S; Omori M; Gemba K; Ueoka H; Tanimoto M Anticancer Drugs; 2008 Apr; 19(4):431-3. PubMed ID: 18454054 [TBL] [Abstract][Full Text] [Related]
3. [Effective palliative chemotherapy in a patient with collecting duct carcinoma of a unilateral kidney associated with anuria. Case report]. Kullmann T; Pintér T; Szepesvári Z; Kránitz N; Culine S Orv Hetil; 2016 Mar; 157(11):436-9. PubMed ID: 26947093 [TBL] [Abstract][Full Text] [Related]
4. Metastatic Collecting (Bellini) Duct Carcinoma Presented in a Young Patient: A Case Report and Review of the Literature. Klang E; Lawson P; Yonat H; Michal Amitai M Isr Med Assoc J; 2017 Dec; 19(12):777-778. PubMed ID: 29235742 [No Abstract] [Full Text] [Related]
5. Gemcitabine in pre-treated advanced renal carcinoma: a feasibility study. Casali M; Marcellini M; Casali A; Giuntini T; Galante E; Ferrone C J Exp Clin Cancer Res; 2001 Jun; 20(2):195-8. PubMed ID: 11484974 [TBL] [Abstract][Full Text] [Related]
6. Carcinoma of the collecting ducts of Bellini of the kidney: adjuvant chemotherapy followed by multikinase-inhibition with sunitinib. Staehler M; Haseke N; Schöppler G; Stadler T; Karl A; Siebels M; Ihrler S; Stief CG Eur J Med Res; 2008 Nov; 13(11):531-5. PubMed ID: 19073390 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of leptomeningeal metastases in a patient with renal carcinoma responding to 5-fluorouracil and gemcitabine. Tippin DB; Reeves W; Vogelzang NJ J Urol; 1999 Jul; 162(1):155-6. PubMed ID: 10379761 [No Abstract] [Full Text] [Related]
8. Curability of poor-risk metastatic sarcomatoid renal cell carcinoma with the combination of gemcitabine, 5-fluorouracil, and interferon-alfa: a case report of a 55-year-old man with a 10-year complete remission. Conter HJ; Lim ZD; Ng CS; Millikan RE; Tannir NM Clin Genitourin Cancer; 2013 Sep; 11(3):370-3. PubMed ID: 23665133 [No Abstract] [Full Text] [Related]
9. Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: results of a GETUG (Groupe d'Etudes des Tumeurs Uro-Génitales) study. Oudard S; Banu E; Vieillefond A; Fournier L; Priou F; Medioni J; Banu A; Duclos B; Rolland F; Escudier B; Arakelyan N; Culine S; J Urol; 2007 May; 177(5):1698-702. PubMed ID: 17437788 [TBL] [Abstract][Full Text] [Related]
10. Carcinoma of the collecting ducts of Bellini of the kidney: adjuvant chemotherapy followed by multikinase inhibition with sunitinib. Staehler M; Schöppler G; Haseke N; Stadler T; Karl A; Siebels M; Ihrler S; Stief CG Clin Genitourin Cancer; 2009 Jan; 7(1):58-61. PubMed ID: 19213670 [TBL] [Abstract][Full Text] [Related]
11. Major response and clinical benefit following third-line treatment for Bellini duct carcinoma. Fakhrai N; Haitel A; Balassy C; Zielinski CC; Schmidinger M Wien Klin Wochenschr; 2005 Jan; 117(1-2):63-5. PubMed ID: 15986594 [TBL] [Abstract][Full Text] [Related]
12. Gemcitabine in advanced renal cell carcinoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group. Mertens WC; Eisenhauer EA; Moore M; Venner P; Stewart D; Muldal A; Wong D Ann Oncol; 1993 Apr; 4(4):331-2. PubMed ID: 8518225 [TBL] [Abstract][Full Text] [Related]
13. [Carcinoma of the Bellini collecting duct in paediatric patients: a case report and review of the literature]. Gurrera A; Amico P; Di Cataldo A; Vasquez E; Magro G Pathologica; 2007 Oct; 99(5):301-5. PubMed ID: 18354951 [TBL] [Abstract][Full Text] [Related]
14. Gemcitabine: a phase II study in patients with advanced renal cancer. De Mulder PH; Weissbach L; Jakse G; Osieka R; Blatter J Cancer Chemother Pharmacol; 1996; 37(5):491-5. PubMed ID: 8599874 [TBL] [Abstract][Full Text] [Related]
15. Durable remission of metastatic renal cell carcinoma with gemcitabine and capecitabine after failure of targeted therapy. Richey SL; Ng C; Lim ZD; Jonasch E; Tannir NM J Clin Oncol; 2011 Mar; 29(8):e203-5. PubMed ID: 21172884 [No Abstract] [Full Text] [Related]
16. Collecting duct carcinoma producing granulocyte-colony-stimulating factor (G-CSF). Sugiura S; Makiyama K; Nakaigawa N; Yao M; Kubota Y; Oshiro H Int J Urol; 2007 Jun; 14(6):555-7. PubMed ID: 17593104 [TBL] [Abstract][Full Text] [Related]
18. An unusual case of Bellini duct carcinoma. Anjum MI; Ting PY; Shrotri N; Randall B; Mufti GR Int Urol Nephrol; 1996; 28(5):695-8. PubMed ID: 9061430 [No Abstract] [Full Text] [Related]
19. Cardiac metastasis of renal cell carcinoma without inferior vena cava involvement: case report. Topçuoğlu M; Yeşilkaya Y; Kılınçer A Turk Kardiyol Dern Ars; 2013 Mar; 41(2):154-6. PubMed ID: 23666305 [TBL] [Abstract][Full Text] [Related]
20. Sorafenib in combination with gemcitabine plus cisplatin chemotherapy in metastatic renal collecting duct carcinoma: A prospective, multicentre, single-arm, phase 2 study. Sheng X; Cao D; Yuan J; Zhou F; Wei Q; Xie X; Cui C; Chi Z; Si L; Li S; Mao L; Lian B; Tang B; Yan X; Wang X; Kong Y; Dai J; Bai X; Zhou L; Guo J Eur J Cancer; 2018 Sep; 100():1-7. PubMed ID: 29933095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]